US Stock MarketDetailed Quotes
MSLP MusclePharm
- 0.006100
- 0.0000000.00%
15min DelayClose Dec 15 16:00 ET
209.53KMarket Cap-10P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.006100Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)34.35MShares0.04050052wk High-0.01P/B75.16KFloat Cap0.00050052wk Low--Dividend TTM12.32MShs Float3.000000Historical High--Div YieldTTM0.00%Amplitude0.000200Historical Low--Avg Price1Lot Size
MusclePharm Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -3,755.10%-3.58M | -826.50%-8.04M | -62.19%-5.58M | -213.63%-1.57M | -196.80%-997K | -39.13%98K | 86.70%-868K | -50.13%-3.44M | 25.59%1.38M | 303.96%1.03M |
| Net income from continuing operations | -6,803.19%-6.3M | -503.96%-12.87M | -340.28%-6.78M | -680.09%-3.93M | -789.72%-2.25M | 256.67%94K | 116.83%3.19M | 181.53%2.82M | 113.35%678K | 95.70%-253K |
| Operating gains losses | ---- | -503.13%-965K | ---- | ---- | ---- | ---- | -3,300.00%-160K | --16K | ---165K | --0 |
| Depreciation and amortization | -57.14%36K | -28.82%331K | -13.68%82K | -20.95%83K | -32.79%82K | -41.26%84K | -29.44%465K | -36.67%95K | -32.26%105K | -22.78%122K |
| Other non cash items | --3.18M | 278.76%2.65M | ---- | ---- | ---- | ---- | -294.62%-1.48M | -2,306.12%-1.08M | -313.17%-518K | -80.73%69K |
| Change In working capital | -275.48%-582K | 152.86%1.78M | 89.16%-579K | 66.67%1.91M | -34.28%604K | -91.36%-155K | -132.24%-3.36M | -549.03%-5.34M | -80.78%1.14M | -79.57%919K |
| -Change in receivables | -298.28%-2.53M | 121.91%625K | 134.82%794K | -26.60%-733K | -190.61%-714K | 263.64%1.28M | -297.51%-2.85M | -687.63%-2.28M | -125.72%-579K | 144.98%788K |
| -Change in inventory | 310.59%855K | -119.04%-702K | -142.65%-145K | -100.51%-19K | -3.94%-132K | -51.49%-406K | -58.38%3.69M | -87.23%340K | 161.13%3.74M | -111.56%-127K |
| -Change in prepaid assets | -101.14%-6K | 1,330.77%480K | 1,002.67%677K | -2,693.33%-389K | -169.79%-335K | 214.81%527K | 92.61%-39K | 74.32%-75K | 112.82%15K | 266.41%480K |
| -Change in payables and accrued expense | 198.05%1.61M | 167.02%3.15M | 108.65%298K | 240.54%2.98M | 486.01%1.52M | -230.97%-1.64M | -6,618.57%-4.7M | -97.25%-3.44M | -196.19%-2.12M | -108.12%-393K |
| -Change in other current assets | ---- | --0 | -452.50%-423K | -19.05%68K | ---- | ---- | -22.68%549K | -32.20%120K | -52.27%84K | -3.93%171K |
| -Change in other current liabilities | ---465K | ---1.78M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Change in other working capital | -147.13%-41K | ---- | ---- | ---- | ---- | --87K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -3,755.10%-3.58M | -826.50%-8.04M | -62.19%-5.58M | -213.63%-1.57M | -196.80%-997K | -39.13%98K | 86.70%-868K | -50.13%-3.44M | 25.59%1.38M | 303.96%1.03M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -100.92%-2K | -50.00%1K | 0 | 1K | -136.36%-4K | 1,776.92%218K | 2K | 205K | 0 |
| Net PPE purchase and sale | --0 | -100.92%-2K | -50.00%1K | --0 | --1K | -136.36%-4K | 1,776.92%218K | --2K | --205K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -100.92%-2K | -50.00%1K | --0 | --1K | -136.36%-4K | 1,776.92%218K | --2K | --205K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 292.23%2.89M | 547.99%7.26M | 47.31%6.41M | 154.61%935K | 426.44%1.42M | -38.58%-1.51M | -80.48%1.12M | 91.30%4.35M | -163.38%-1.71M | -144.16%-435K |
| Net issuance payments of debt | 292.23%2.89M | 623.64%8.11M | 66.79%7.26M | 154.61%935K | 426.44%1.42M | -38.58%-1.51M | -80.48%1.12M | 91.30%4.35M | -163.38%-1.71M | -144.16%-435K |
| Net other financing activities | ---- | ---848K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 292.23%2.89M | 547.99%7.26M | 47.31%6.41M | 154.61%935K | 426.44%1.42M | -38.58%-1.51M | -80.48%1.12M | 91.30%4.35M | -163.38%-1.71M | -144.16%-435K |
| Net cash flow | ||||||||||
| Beginning cash position | -38.94%1.22M | 30.74%2M | -64.61%384K | -16.24%1.02M | -4.21%592K | 30.74%2M | -33.88%1.53M | -29.68%1.09M | 10.57%1.21M | 0.82%618K |
| Current changes in cash | 51.17%-689K | -265.61%-780K | -8.61%839K | -393.75%-632K | -28.74%424K | -54.38%-1.41M | 159.25%471K | 6,657.14%918K | -128.57%-128K | 23.96%595K |
| End cash Position | -9.80%534K | -38.94%1.22M | -38.94%1.22M | -64.61%384K | -16.24%1.02M | -4.21%592K | 30.74%2M | 30.74%2M | -29.68%1.09M | 10.57%1.21M |
| Free cash flow | -3,910.64%-3.58M | -822.48%-8.04M | -62.16%-5.58M | -213.96%-1.57M | -196.70%-996K | -41.61%94K | 86.66%-872K | -50.13%-3.44M | 25.23%1.38M | 303.96%1.03M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg